Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SHR-1681Phase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors
- SHR-2017Phase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors
- SHR-3276Phase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors
- SHR-4298Phase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors
- SHR-4394Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- SHR-4602Phase 21 trial
Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors
- SHR-4642Phase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors
- SHR-7367Phase 21 trial
Shanghai Hengrui Pharmaceutical Co., Ltd. · Solid Tumor
- SHR-8203Phase 21 trial
Beijing Suncadia Pharmaceuticals Co., Ltd · Solid Tumors
- SHR-9803Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Advanced Solid Tumors
- SHR3680Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- SKB105Phase 21 trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors
- SKB315Phase 21 trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Gastroesophageal Junction Adenocarcinoma
- SKB565Phase 21 trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors
- SL-28Phase 21 trial
Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic
- SMP-656Phase 21 trial
Chengdu SciMount Pharmatech Co., Ltd. · HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
- SMP3124LPPhase 21 trial
Sumitomo Pharma America, Inc. · Solid Tumor
- SNB-101Phase 21 trial
SN BioScience · Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- SNV4818Phase 21 trial
Pikavation Therapeutics, Inc. · Advanced Solid Tumors
- SOA101Phase 21 trial
Shine-On Biomedical Co., Ltd. · Solid Tumors
- SOT106Phase 21 trial
SOTIO Biotech a.s. · Osteosarcoma Metastatic, Soft Tissue Sarcoma (STS), Osteosarcoma, Advanced
- SOT109Phase 21 trial
SOTIO Biotech a.s. · Colorectal Cancer (Locally Advanced or Metastatic)
- SotevtamabAB-16B5Phase 21 trial
Alethia Biotherapeutics · Metastatic Colorectal Cancer
- SP-002Phase 21 trial
Stamford Pharmaceuticals, Inc. · Basal Cell Carcinoma
- SPH5030Phase 21 trial
Shanghai Pharmaceuticals Holding Co., Ltd · Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
- SRP1020Phase 21 trial
Shanghai SciBrunch Therapeutics Co., Ltd. · Advanced Solid Tumors, PARP Inhibitor
- ST-067Phase 21 trial
Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma
- ST101Phase 21 trial
Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer
- STC-1010Phase 21 trial
Brenus Pharma · Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
- STC-15Phase 21 trial
STORM Therapeutics LTD · Solid Tumor, Sarcoma, Leiomyosarcoma
- STK-012Phase 21 trial
Synthekine · Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC
- STM-416Phase 21 trial
SURGE Therapeutics · Non-muscle-invasive Bladder Cancer
- STRO-002Phase 21 trial
Tasly Pharmaceutical Group Co., Ltd · Neoplasm Malignant
- STX-001Phase 21 trial
Strand Therapeutics Inc. · Advanced Solid Tumor
- STX-003Phase 21 trial
Strand Therapeutics Inc. · Advanced Solid Tumor
- STX-241PFL-241Phase 21 trial
Pierre Fabre Medicament · Non-small Cell Lung Cancer (NSCLC)
- STX-721PFL-721, EscalatedPhase 21 trial
Pierre Fabre Medicament · Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation
- SV-102Phase 21 trial
Syncromune, Inc. · Metastatic Castration-resistant Prostate Cancer
- SX-682Phase 21 trial
Syntrix Biosystems, Inc. · Metastatic Castration-resistant Prostate Cancer
- SYHX2011Phase 21 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Advanced Breast Cancer
- SYS6006Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors
- SYS6023Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Breast Cancer
- SYS6045Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors
- SYS6062Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)
- SYS6088Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced/Metastatic Solid Tumors
- TagmokitugPhase 21 trial
Coherus Oncology, Inc. · Solid Tumor
- TAK-188Phase 21 trial
Takeda · Advanced or Metastatic Solid Tumors
- TAK-505Phase 21 trial
Takeda · Malignant Solid Tumors
- TAS0953HM06Phase 21 trial
Taiho Pharmaceutical Co., Ltd. · RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.